[{"data":1,"prerenderedAt":70},["ShallowReactive",2],{"case-national-pharmacy-policy":3},{"id":4,"title":5,"alt":6,"body":7,"date":49,"description":50,"extension":51,"img":52,"meta":53,"navigation":54,"path":55,"quote":56,"quote_author":57,"results":58,"seo":63,"services":64,"stem":67,"tagline":68,"__hash__":69},"cases\u002Fcases\u002Fnational-pharmacy-policy.md","National Pharmacy Policy During Covid-19","National Pharmacy Policy case study",{"type":8,"value":9,"toc":42},"minimark",[10,15,19,22,25,29,32,35,39],[11,12,14],"h2",{"id":13},"overview","Overview",[16,17,18],"p",{},"NationalPolicyOrg* focuses on advocating for pro-patient and pro-pharmacy public policy; communicating the value of community pharmacy as the face of neighborhood healthcare; and fostering business community and solutions through effective meetings and other member programs.",[16,20,21],{},"NationalPolicyOrg* represents traditional drug stores, supermarkets and mass merchants with pharmacies. Chains operate nearly 40,000 pharmacies, and the 80 chain member companies include regional chains, with a minimum of four stores, and national companies. Chains employ nearly 3 million individuals, including 155,000 pharmacists. They fill over 3 billion prescriptions yearly, and help patients use medicines correctly and safely, while offering innovative services that improve patient health and healthcare affordability.",[16,23,24],{},"NationalPolicyOrg* was seeking a strategic thinker who could bring a wide-variety of expertise in pharmacy to help architect policy change and deliver insightful analytics. We were selected to that position just prior to Covid-19 and were initially tasked with several high-impact initiatives. As the pandemic began, our focus shifted to federal policy and collaboration with the White House and other government bodies.",[11,26,28],{"id":27},"process","Process",[16,30,31],{},"Our strategic approach began with a thorough analysis of the pharmacy landscape and the regulatory environment. We worked closely with the leadership team to identify the highest-impact areas where policy change could drive meaningful improvement for pharmacies and pharmacists across the country.",[16,33,34],{},"As the Covid-19 pandemic unfolded, we quickly pivoted to support urgent policy needs, including federal and state reimbursement analysis for pharmacist-administered immunizations and other Covid-19 related initiatives.",[11,36,38],{"id":37},"results","Results",[16,40,41],{},"Our work ultimately drove industry-wide change across policy and reimbursement for pharmacies and pharmacists both before and during the Covid-19 pandemic.",{"title":43,"searchDepth":44,"depth":44,"links":45},"",2,[46,47,48],{"id":13,"depth":44,"text":14},{"id":27,"depth":44,"text":28},{"id":37,"depth":44,"text":38},"2020-03-01","Federal and State Policy and Reimbursement for Pharmacist Immunizations & Covid-19 Initiatives","md","https:\u002F\u002Fmedia.milligram-health.com\u002Fmilligram-web\u002Fimages\u002Fgovernment_1080_do52rn.jpg",{},true,"\u002Fcases\u002Fnational-pharmacy-policy","NationalPolicyOrg is at the front-lines of policy change for pharmacy. I was honored to assist in many areas which ultimately drove industry-wide change across policy and reimbursement for pharmacies and pharmacists both before and during the Covid-19 pandemic.","Dr. Barus, Founder & President",[59,60,61,62],"Drove industry-wide policy change for pharmacies and pharmacists","Federal and state policy analysis and recommendations","Reimbursement strategy for pharmacist immunizations","Covid-19 initiative analytics and insights",{"title":5,"description":50},[65,66],"Product Strategy & Innovation","Analytics & AI","cases\u002Fnational-pharmacy-policy","Driving industry-wide practice change during pandemic","TTrR4hiyt7ejSBq6uWark_-v24uFOMnPCLGeAmphqYk",1776173871095]